CClinicalTrials.gg
CompletedNCT06298747pulsedrfUpdated Mar 15, 2024

Ultrasound-guided Selective Cervical Root Pulsed Radiofrequency Therapy in Patients With Cervical Radicular Pain

An observational study in Cervical Pain, sponsored by Diskapi Teaching and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-15.

Sponsored by Diskapi Teaching and Research Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
45
Ages
18 Years and older
Sex
All
01

Study summary

Chronic cervical pain is a common disorder with a prevalence of approximately 35% in adults. Cervical radicular pain is defined as radiating pain in the upper limb caused by compression or inflammation of the nerve roots ascending from the intervertebral foramen to the spinal cord, due to disc herniation or spinal stenosis. C7 and C6 are the two most commonly affected nerve roots. Various treatment modalities are available, including oral medications, physiotherapy, and epidural steroid injections. However, chronic and persistent pain that develops as a result of some patients not responding to these treatments. Ultrasound-guided selective cervical nerve root block and pulsed radiofrequency are interventional treatments used in patients with radicular cervical pain unresponsive to conservative treatments. Pulsed radiofrequency (PRF) treatment of peripheral nerves may provide long-term pain relief in patients with short-term pain relief with a local anesthetic block. Studies have shown the effectiveness of PRF therapy applied to selective cervical nerve roots in relieving cervical radicular pain.

Read the detailed description

Pulsed radiofrequency treatment applied to selective cervical nerve roots (C5, C6, and C7) under ultrasound guidance is frequently used in patients with cervical radicular pain due to cervical disc herniation who do not respond adequately to medical treatment and physiotherapy.

Pain intensity was evaluated at baseline and 1,3 and 6 months after US-guided selective cervical nerve root PRF treatment using VAS (Visual analog scale). The primary outcome measure was percent reduction in pain, with 50% pain relief lasting at least 6 months was defined as a positive categorical outcome.

Patients' functionality and neuropathic pain status were assessed using the Neck Disability Index (NDI) and Douleur Neuropathique 4 Questions (DN4) at baseline and 1,3 and 6 months after US-guided selective cervical nerve root PRF treatment, respectively. Secondary outcome measure was defined as a positive categorical outcome of 50% or more improvement in these scores for at least 6 months.

In addition, demographic data such as age (years), gender, duration of pain (months), pain side (right or left), affected cervical nerve root level (one or multiple levels), and history of surgery for cervical disc herniation and analgesic use (nonsteroidal anti-inflammatory drugs or opioids) were obtained from patient data and retrospectively analyzed the patient's electronic medical history records.

The primary aim of this study was to determine the efficacy of US-SCNR PRF treatment, and the clinical and demographic variables associated with treatment outcomes. The secondary aim of this study was to determine the improvement in functionality and neuropathic pain status of patients after the procedure, and treatment-related adverse events.

02

Conditions studied

  • Cervical Pain

Browse trials for

Keywords

  • cervical radicular pain
  • ultrasonography
  • cervical nerve root
  • pulsed radiofrequency
  • analgesia
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 254 are open to participants now.

This study's enrollment of 45 is below the median of 90 across 212 observational studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Diskapi Teaching and Research Hospital is the lead sponsor of 101 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients with cervical radicular pain unresponsive to conservative treatments

Inclusion criteria

  • age ≥ 18 years
  • radicular pain radiating only to the neck and one arm for more than 12 weeks
  • no response to conservative treatment (including analgesics and physiotherapy modalities)
  • access to clinical data

Exclusion criteria

Exclusion Criteria:

  • inadequate medical records with missing Numerical Rating Scale (NRS), Neck Disability Index (NDI), and DN4 (Douleur Neuropathique 4 Questions) scores
  • patients lost to follow-up within six months after the procedure
  • history of malignancy
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
45 participants (actual)
Patient registry
No

Groups and cohorts

  • Selective cervical nerve root pulsed radiofrequency

    A 5-12 MHz linear US probe was used during the procedure. C7 has a more prominent posterior tubercle and a rudimentary anterior tubercle. C5 and C6 have more prominent and smooth anterior and posterior tubercles, respectively. After visualizing the hypoechoic nerve root between the tubercles of the transverse process, the surrounding vascular structures were identified and RF canula is used. After approaching the hypoechoic nerve root, after sensory and motor stimulation, PRF was applied to each nerve root with a current of 1.0-1.2 V at a frequency of 2 Hz for 4 minutes at 42 °C.

    Other: Selective cervical nerve root pulsed radiofrequency

Interventions

  • OtherSelective cervical nerve root pulsed radiofrequency

    A 5-12 MHz linear US probe was used during the procedure. C7 has a more prominent posterior tubercle and a rudimentary anterior tubercle. C5 and C6 have more prominent and smooth anterior and posterior tubercles, respectively. After visualizing the hypoechoic nerve root between the tubercles of the transverse process, the surrounding vascular structures were identified and RF canula is used. After approaching the hypoechoic nerve root, after sensory and motor stimulation, PRF was applied to each nerve root.

06

What researchers measure

Primary outcomes

  1. VAS

    Visual analogue scales (VAS) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients and use this to achieve a rapid (statistically measurable and reproducible) classification of symptom severity and disease control. (minimum value is 0 and maximum value is 10)

    Time frame: Change from Baseline VAS at 6 months

Secondary outcomes

  1. Neck Disability Index (NDI)

    NDI is a self-report questionnaire that measures the impact of neck pain on patient's daily activities and quality of life. It consists of ten items assessing pain intensity, self-care, lifting, reading, headache, concentration, work, driving, sleep, and leisure. Each item is scored between 0 and 5, with higher scores indicating more disability.

    Time frame: Change from Baseline NDI at 6 months

  2. Douleur Neuropathique 4 Questions (DN4)

    The DN4 scale provides information on whether pain has a neuropathic character. It is scored according to the presence of burning, coldness, or electric shock sensation in the pain, tingling, numbness, stinging, or itching sensation in the same region, presence of touch or needle hypoesthesia on examination, and occurrence of pain in the same region with a brush. Although the maximum score was 10, a score \>4 indicated the presence of neuropathic pain.

    Time frame: Change from Baseline NDI at 6 months

07

Study locations

1 site
  • Ankara Etlik City Hospital
    Ankara, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06298747
Lead sponsor
Diskapi Teaching and Research Hospital
Responsible party
Damla Yürük (Principal investigator, Diskapi Teaching and Research Hospital) — Principal investigator
First posted
Mar 7, 2024
Start date
Nov 1, 2022
Primary completion
Jul 1, 2023
Completion
Jul 2, 2023
Last update
Mar 15, 2024

Study contacts

Ömer Taylan Akkaya, MD
study director · Diskapi Teaching and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion